{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:58:43Z","timestamp":1791259123182,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2507000"],"award-info":[{"award-number":["2023YFC2507000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","award":["z22023010"],"award-info":[{"award-number":["z22023010"]}],"id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ40912"],"award-info":[{"award-number":["2023JJ40912"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370779"],"award-info":[{"award-number":["82370779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377093"],"award-info":[{"award-number":["22377093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303571"],"award-info":[{"award-number":["82303571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LR23C100001"],"award-info":[{"award-number":["LR23C100001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drup.2025.101323","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:56:28Z","timestamp":1762304188000},"page":"101323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Nanoparticles-mediated mitochondrial relocation of lipid-lowering drugs shape energy metabolism to conquer acquired immune resistance"],"prefix":"10.1016","volume":"84","author":[{"given":"Cheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-1395","authenticated-orcid":false,"given":"Zaigang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenpeng","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-2428","authenticated-orcid":false,"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101323_bib1","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1038\/s41467-022-32849-1","article-title":"Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells","volume":"13","author":"Adamik","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101323_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125203","article-title":"Recent advances in lipid-based nanocarriers for advanced skin cancer therapy","volume":"670","author":"Ali","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drup.2025.101323_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43440-023-00553-6","article-title":"Lipid-lowering drugs and cancer: an updated perspective","volume":"76","author":"Alizadehasl","year":"2024","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.drup.2025.101323_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ccell.2023.12.018","article-title":"Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms","volume":"42","author":"Bejarano","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101323_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433237","article-title":"Immunological signatures from irradiated cancer-associated fibroblasts","volume":"15","author":"Berzaghi","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2025.101323_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.104.068312","article-title":"Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I","volume":"311","author":"Brunmair","year":"2004","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.drup.2025.101323_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40425-019-0540-1","article-title":"Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)","volume":"7","author":"Carvajal-Hausdorf","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101323_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12951-023-02078-9","article-title":"B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC","volume":"21","author":"Chen","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.drup.2025.101323_bib9","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/s41467-024-46735-5","article-title":"CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer","volume":"15","author":"Cheng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101323_bib10","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.molcel.2021.03.037","article-title":"Energy status dictates PD-L1 protein abundance and anti-tumor immunity to enable checkpoint blockade","volume":"81","author":"Dai","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101323_bib11","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1021\/acsnano.2c12217","article-title":"Engineering MMP-2 Activated Nanoparticles Carrying B7-H3 Bispecific Antibodies for Ferroptosis-Enhanced Glioblastoma Immunotherapy","volume":"17","author":"Fan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101323_bib12","doi-asserted-by":"crossref","unstructured":"M. Fang, J. Zheng, Q. Song, J. Huang, R. Cao, P. Li, Y. Chen and L. Zhang, Breaking Apoptosis-Induced Immune Silence: Ultrasound-Activated Nano-Oncolytic Therapy Reinvigorates Antitumor Immunity, Advanced materials (Deerfield Beach, Fla.) 37 (2025), p. e2508681.","DOI":"10.1002\/adma.202508681"},{"key":"10.1016\/j.drup.2025.101323_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","article-title":"New frontiers in immune checkpoint B7-H3 (CD276) research and drug development","volume":"22","author":"Getu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101323_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","article-title":"PD-L1 degradation pathway and immunotherapy for cancer","volume":"11","author":"Gou","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101323_bib15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1159\/000453175","article-title":"Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3","volume":"40","author":"He","year":"2016","journal-title":"Cell Physiol. Biochem"},{"key":"10.1016\/j.drup.2025.101323_bib16","article-title":"Metformin Mediated PD-L1 Downregulation in Combination with Photodynamic-Immunotherapy for Treatment of Breast Cancer","volume":"31","author":"Hu","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.drup.2025.101323_bib17","article-title":"Lipid Nanoparticle Delivery System for mRNA Encoding B7H3-redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors","volume":"10","author":"Huang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2025.101323_bib18","doi-asserted-by":"crossref","first-page":"11937","DOI":"10.1074\/jbc.M110.203661","article-title":"Reversible high affinity inhibition of phosphofructokinase-1 by acyl-CoA: a mechanism integrating glycolytic flux with lipid metabolism","volume":"286","author":"Jenkins","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2025.101323_bib19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12885-024-11933-3","article-title":"A promising target for breast cancer: B7-H3","volume":"24","author":"Jiang","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.drup.2025.101323_bib20","first-page":"31","article-title":"Nanoparticle-Mediated Lipid Metabolic Reprogramming of T Cells in Tumor Microenvironments for Immunometabolic Therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Nanomicro Lett."},{"key":"10.1016\/j.drup.2025.101323_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2015.05.059","article-title":"Novel fenofibric acid-loaded controlled release pellet bioequivalent to choline fenofibrate-loaded commercial product in beagle dogs","volume":"490","author":"Kim","year":"2015","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.drup.2025.101323_bib22","first-page":"1227","article-title":"B7-H3: An Attractive Target for Antibody-based Immunotherapy, Clinical cancer research: an official","volume":"27","author":"Kontos","year":"2021","journal-title":"J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101323_bib23","article-title":"Comprehensive metabolomic analysis identifies key biomarkers and modulators of immunotherapy response in NSCLC patients, Drug resistance updates: reviews and commentaries in antimicrobial and anticancer","volume":"77","author":"Lee","year":"2024","journal-title":"chemotherapy"},{"key":"10.1016\/j.drup.2025.101323_bib24","first-page":"47","article-title":"A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations","volume":"4","author":"Ling","year":"2013","journal-title":"Cardiol. Res"},{"key":"10.1016\/j.drup.2025.101323_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122796","article-title":"Genetically engineered CD276-anchoring biomimetic nanovesicles target senescent escaped tumor cells to overcome chemoresistant and immunosuppressive breast cancer","volume":"313","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.drup.2025.101323_bib26","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101323_bib27","article-title":"The Role of CD276 in Cancers","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2025.101323_bib28","doi-asserted-by":"crossref","first-page":"27487","DOI":"10.1021\/acsnano.4c08055","article-title":"Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and gamma-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma","volume":"18","author":"Lv","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.drup.2025.101323_bib29","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.drudis.2022.05.007","article-title":"Impact of fenofibrate on NAFLD\/NASH: A genetic perspective","volume":"27","author":"Mahmoudi","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drup.2025.101323_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00204-012-0809-3","article-title":"Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation","volume":"86","author":"Mar\u00edn-Hern\u00e1ndez","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drup.2025.101323_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2326-6066.CIR-21-0407","article-title":"B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression","volume":"10","author":"Miyamoto","year":"2022","journal-title":"Cancer Immunol. Res"},{"key":"10.1016\/j.drup.2025.101323_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41577-021-00580-5","article-title":"Immune-based therapies in cardiovascular and metabolic diseases: past, present and future","volume":"21","author":"Murphy","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drup.2025.101323_bib33","article-title":"Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1\/PD-L1 blockade","volume":"66","author":"Pang","year":"2022","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101323_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm7012","article-title":"The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development","volume":"8","author":"Picarda","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.drup.2025.101323_bib35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41423-023-01019-8","article-title":"Recent advancements in the B7\/CD28 immune checkpoint families: new biology and clinical therapeutic strategies","volume":"20","author":"Pulanco","year":"2023","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.drup.2025.101323_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113730","article-title":"Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate","volume":"223","author":"Qiao","year":"2021","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.drup.2025.101323_bib37","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","article-title":"Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration","volume":"16","author":"Qiu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drup.2025.101323_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12951-020-00663-w","article-title":"The mTOR\/ULK1 signaling pathway mediates the autophagy-promoting and osteogenic effects of dicalcium silicate nanoparticles","volume":"18","author":"Ruolan","year":"2020","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.drup.2025.101323_bib39","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41591-023-02284-w","article-title":"Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial","volume":"29","author":"Shenderov","year":"2023","journal-title":"Nat. Med"},{"key":"10.1016\/j.drup.2025.101323_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf6724","article-title":"Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies","volume":"15","author":"Shi","year":"2023","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.drup.2025.101323_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat. Rev. Mol. Cell Bio"},{"key":"10.1016\/j.drup.2025.101323_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201704196","article-title":"Structure-Guided Design and Synthesis of a Mitochondria-Targeting Near-Infrared Fluorophore with Multimodal Therapeutic Activities","volume":"29","author":"Tan","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101323_bib43","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1038\/s41467-024-50251-x","article-title":"CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma","volume":"15","author":"Tian","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101323_bib44","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s13046-023-02838-3","article-title":"CD276-CAR T cells and Dual-CAR T cells targeting CD276\/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models","volume":"42","author":"Timpanaro","year":"2023","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101323_bib45","article-title":"Overcoming Cancer Resistance to Platinum Drugs by Inhibiting Cholesterol Metabolism","volume":"62","author":"Wang","year":"2023","journal-title":"Angew. Chem. Int Ed. Engl."},{"key":"10.1016\/j.drup.2025.101323_bib46","article-title":"In Situ Vaccination with Mitochondria-Targeting Immunogenic Death Inducer Elicits CD8(+) T Cell-Dependent Antitumor Immunity to Boost Tumor Immunotherapy","volume":"10","author":"Wang","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2025.101323_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2025.100092","article-title":"Tumor microenvironment-responsive nanoplatforms for enhanced cancer immunotherapy: Advances and synergistic strategies","volume":"4","author":"Wu","year":"2025","journal-title":"Nano TransMed"},{"key":"10.1016\/j.drup.2025.101323_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008662","article-title":"CD276 regulates the immune escape of esophageal squamous cell carcinoma through CXCL1-CXCR2 induced NETs","volume":"12","author":"Xiong","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101323_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf6732","article-title":"Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer","volume":"15","author":"Yamada","year":"2023","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.drup.2025.101323_bib50","doi-asserted-by":"crossref","first-page":"7726","DOI":"10.1111\/febs.16181","article-title":"PPAR\u03b1 at the crossroad of metabolic-immune regulation in cancer","volume":"289","author":"Zeng","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.drup.2025.101323_bib51","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1038\/s41467-024-51096-0","article-title":"ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4(+) macrophage infiltration","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101323_bib52","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbrc.2017.07.001","article-title":"Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells","volume":"490","author":"Zhang","year":"2017","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.drup.2025.101323_bib53","article-title":"D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101323_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1535-7163.MCT-20-0446","article-title":"Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2025.101323_bib55","doi-asserted-by":"crossref","first-page":"5926","DOI":"10.7150\/thno.56490","article-title":"ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101323_bib56","article-title":"Mitochondria Energy Metabolism Depression as Novel Adjuvant to Sensitize Radiotherapy and Inhibit Radiation Induced-Pulmonary Fibrosis","author":"Zhou","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2025.101323_bib57","article-title":"Mitochondria-Targeted Nanoadjuvants Induced Multi-Functional Immune-Microenvironment Remodeling to Sensitize Tumor Radio-Immunotherapy","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2025.101323_bib58","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jconrel.2022.11.004","article-title":"Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy","volume":"352","author":"Zhou","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.drup.2025.101323_bib59","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1016\/j.apsb.2024.05.028","article-title":"Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy","volume":"14","author":"Zhou","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2025.101323_bib60","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-23-4099","article-title":"A Dual-Payload Antibody-Drug Conjugate Targeting CD276\/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer","author":"Zhou","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101323_bib61","article-title":"Recent progress, perspectives, and issues of engineered PD-L1 regulation nano-system to better cure tumor: A review","volume":"254","author":"Zhou","year":"2023","journal-title":"Int J. Biol. Macromol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:28:14Z","timestamp":1773296894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"alternative-id":["S1368764625001268"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101323","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticles-mediated mitochondrial relocation of lipid-lowering drugs shape energy metabolism to conquer acquired immune resistance","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101323"}}